Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer

References

• JemalASiegelRWardECancer Statistics, 2008CA: A Cancer Journal for Clinicians2008582719618287387
   PubMed Web of Science ®Google Scholar
• SamadderNJVierkantRATillmansLSAssociations Between Colorectal Cancer Molecular Markers and Pathways With Clinicopathologic Features in Older WomenGastroenterology2013145356(2348e341356
   Google Scholar
• PhippsAILimburgPJBaronJAAssociation Between Molecular Subtypes of Colorectal Cancer and Patient SurvivalGastroenterology20151488717787
   Google Scholar
• GundersonLLJessupJMSargentDJGreeneFLStewartAKRevised TN Categorization for Colon Cancer Based on National Survival Outcomes DataJournal of Clinical Oncology201028226427119949014
   PubMed Web of Science ®Google Scholar
• RossJSTorres-MoraJWagleNJenningsTAJonesDMBiomarker-Based Prediction of Response to Therapy for Colorectal CancerAm J Clin Pathol2010134347849020716806
   PubMed Web of Science ®Google Scholar
• BosmanFTYanPMolecular pathology of colorectal cancerPolish Journal of Pathology201444257266
   Google Scholar
• LochheadPKuchibaAImamuraYMicrosatellite Instability and BRAF Mutation Testing in Colorectal Cancer PrognosticationJNCI: Journal of the National Cancer Institute2013105151151115623878352
   PubMedGoogle Scholar
• PhippsAILimburgPJBaronJAAssociation Between Molecular Subtypes of Colorectal Cancer and Patient SurvivalGastroenterology20151481778725280443
   PubMed Web of Science ®Google Scholar
• StachlerMDRinehartELindemanNOdzeRSrivastavaANovel molecular insights from routine genotyping of colorectal carcinomasHum Pathol201546450751325683705
   PubMed Web of Science ®Google Scholar
• BolandCRGoelAMicrosatellite Instability in Colorectal CancerGastroenterology20101386e207320732087
   PubMed Web of Science ®Google Scholar
• YamamotoHImaiKMicrosatellite instability: an updateArch Toxicol201589689992125701956
   PubMed Web of Science ®Google Scholar
• PeltomakiPLotheRAAaltonenLAMicrosatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndromeCancer Res19935324585358558261393
   PubMed Web of Science ®Google Scholar
• HermanJGUmarAPolyakKIncidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences1998951268706875
   PubMed Web of Science ®Google Scholar
• BertagnolliMMNiedzwieckiDComptonCCMicrosatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803Journal of Clinical Oncology200927111814182119273709
   PubMed Web of Science ®Google Scholar
• SargentDJMarsoniSMongesGDefective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology201028203219322620498393
   PubMed Web of Science ®Google Scholar
• PopatSHubnerRHoulstonRSSystematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology200523360961815659508
   PubMed Web of Science ®Google Scholar
• DaviesHBignellGRCoxCMutations of the BRAF gene in human cancerNature2002417689294995412068308
   PubMed Web of Science ®Google Scholar
• RajagopalanHBardelliALengauerCKinzlerKWVogelsteinBVelculescuVERAF/RAS oncogenes and mismatch-repair statusNature2002418690193412198537
   PubMed Web of Science ®Google Scholar
• PeyssonnauxCEychèneAThe Raf/MEK/ERK pathway: new concepts of activationBiol Cell2001931–2536211730323
   PubMed Web of Science ®Google Scholar
• ZhengGTsengL-HChenGClinical detection and categorization of uncommon and concomitant mutations involving BRAFBMC Cancer201515177926498038
   PubMedGoogle Scholar
• ChenDHuangJ-FLiuKBRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-AnalysisPLoS One201493e9060724594804
   PubMed Web of Science ®Google Scholar
• PhippsAIBuchananDDMakarKWBRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor CharacteristicsCancer Epidemiology Biomarkers & Prevention2012211017921798
   PubMed Web of Science ®Google Scholar
• SamowitzWSSweeneyCHerrickJPoor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon CancersCancer Res200565146063606916024606
   PubMed Web of Science ®Google Scholar
• OginoSShimaKMeyerhardtJAPredictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803Clinical Cancer Research201218389090022147942
   PubMed Web of Science ®Google Scholar
• GavinPGColangeloLHFumagalliDMutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive ValueClinical Cancer Research201218236531654123045248
   PubMed Web of Science ®Google Scholar
• HamiltonSRBRAF Mutation and Microsatellite Instability Status in Colonic and Rectal Carcinoma: Context Really Does MatterJNCI Journal of the National Cancer Institute2013105151075107723878351
   PubMedGoogle Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials2007811617555582
   PubMed Web of Science ®Google Scholar
• DersimonianRLairdNNLMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• BeggCBMazumdarMOperating Characteristics of a Rank Correlation Test for Publication BiasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMSmithGDSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• AltmanDGBlandJMStatistics Notes: Interaction revisited: the difference between two estimatesBMJ2003326738221912543843
   PubMed Web of Science ®Google Scholar
• Y-JLWangPPengJWangXY-WZShenNMeta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal CancerScientific Reports20177190528424486
   PubMedGoogle Scholar
• Fariña-SarasquetaAvan LijnschotenGMoerlandEThe BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology201021122396240220501503
   PubMed Web of Science ®Google Scholar
• Fariña-SarasquetaAvan LijnschotenGMoerlandEThe BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology201021122396240220501503
   PubMed Web of Science ®Google Scholar
• PopoviciVBudinskaEBosmanFTTejparSRothADDelorenziMContext-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancerBMC Cancer2013131
   PubMedGoogle Scholar
• TieJGibbsPLiptonLOptimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutationInt J Cancer201112892075208420635392
   PubMed Web of Science ®Google Scholar
• GoldsteinJTranBEnsorJMulticenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-HAnnals of Oncology20142551032103824585723
   PubMed Web of Science ®Google Scholar
• DienstmannRMasonMJSinicropeFAPrediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyAnnals of Oncology20172851023103128453697
   PubMed Web of Science ®Google Scholar
• OginoSNoshoKKirknerGJCpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerGut2009581909618832519
   PubMed Web of Science ®Google Scholar
• KadowakiSPrognostic value of KRAS and BRAF mutations in curatively resected colorectal cancerWorld J Gastroenterol20152141275128325632202
   PubMed Web of Science ®Google Scholar
• SmithCGFisherDClaesBSomatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy CetuximabClinical Cancer Research201319154104411323741067
   PubMed Web of Science ®Google Scholar
• ChanJCYChanDLDiakosCIThe Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal CancerAnn Surg2017265353954627070934
   PubMed Web of Science ®Google Scholar
• TaiebJZaananALe MalicotKPrognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without CetuximabJAMA Oncol201625643652
   PubMed Web of Science ®Google Scholar
• PaiRKJayachandranPKoongACBRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic FeaturesAm J Surg Pathol201236574475222314188
   PubMed Web of Science ®Google Scholar
• KakarSDengCSahaiVClinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instabilityArchives of Pathology and Laboratory Medicine2008132695896418517279
   PubMed Web of Science ®Google Scholar
• UmedaYNagasakaTMoriYPoor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instabilityJ Hepatobiliary Pancreat Sci201320222323323010994
   PubMed Web of Science ®Google Scholar
• KhanSAMorrisMIdreesKColorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patientsJ Pediatr Surg201651111812181727558481
   PubMed Web of Science ®Google Scholar
• ShaukatAArainMThaygarajanBBondJHSawhneyMIs BRAF Mutation Associated with Interval Colorectal Cancers?Dig Dis Sci20105582352235620300843
   PubMed Web of Science ®Google Scholar
• ZlobecIKovacMErzbergerPCombined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancerInt J Cancer2010127112569257520162668
   PubMed Web of Science ®Google Scholar
• MaestroMLVidaurretaMSanz-CaslaMTRole of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal CancerAnn Surg Oncol20071431229123617195912
   PubMed Web of Science ®Google Scholar
• LeeSChoN-YChoiMYooEJKimJ-HKangGHClinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutationPathol Int200858210411318199160
   PubMed Web of Science ®Google Scholar
• SaridakiZPapadatos-PastosDTzardiMBRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcomeBr J Cancer2010102121762176820485284
   PubMed Web of Science ®Google Scholar
• MarkovicSAnticJDragicevicNHamelinRKrivokapicZHigh-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancerJ Mol Histol201243213714322210186
   PubMed Web of Science ®Google Scholar
• AndréTde GramontAVernereyDAdjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC StudyJournal of Clinical Oncology201533354176418726527776
   PubMed Web of Science ®Google Scholar
• NakajiYOkiENakanishiRPrognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancerJ Cancer Res Clin Oncol2017143115116027672042
   PubMed Web of Science ®Google Scholar
• FrenchAJSargentDJBurgartLJPrognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon CancerClinical Cancer Research200814113408341518519771
   PubMed Web of Science ®Google Scholar
• RothADTejparSDelorenziMPrognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 TrialJournal of Clinical Oncology201028346647420008640
   PubMed Web of Science ®Google Scholar
• TranBKopetzSTieJImpact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerCancer2011117204623463221456008
   PubMed Web of Science ®Google Scholar
• ZlobecIBihlMPSchwarbHTerraccianoLLugliAClinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosisInternational Journal of Cancer2010127236738019908233
   PubMed Web of Science ®Google Scholar
• KaladyMFDejuliusKLSanchezJABRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse PrognosisDiseases of the Colon & Rectum201255212813322228154
   PubMed Web of Science ®Google Scholar
• OginoSShimaKMeyerhardtJAPredictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803Clinical Cancer Research201218389090022147942
   PubMed Web of Science ®Google Scholar
• PhippsAIBuchananDDMakarKWBRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor CharacteristicsCancer Epidemiology Biomarkers & Prevention2012211017921798
   PubMed Web of Science ®Google Scholar
• SylvesterBEHuoDKhramtsovAMolecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single InstitutionClinical Cancer Research201218235035922114137
   PubMed Web of Science ®Google Scholar
• WangefjordSSundströmMZendehrokhNSex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort studyBiol Sex Differ2013411724020794
   PubMedGoogle Scholar
• LinC-CLinJ-KLinT-CThe prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancerJ Surg Oncol2014110445145724964758
   PubMed Web of Science ®Google Scholar
• LueyNToonCWSiosonLA Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal CarcinomaPLoS One201498e10610525153715
   PubMed Web of Science ®Google Scholar
• MalesciABassoGBianchiPMolecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasiaBr J Cancer201411051228123524434431
   PubMed Web of Science ®Google Scholar
• OokiAAkagiKYatsuokaTCombined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancerJ Surg Oncol2014110898298825154726
   PubMed Web of Science ®Google Scholar
• ToonCWChouADesilvaKBRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancerModern Pathology201427564465024157612
   PubMed Web of Science ®Google Scholar
• VenderboschSNagtegaalIDMaughanTSMismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS StudiesClinical Cancer Research201420205322533025139339
   PubMed Web of Science ®Google Scholar
• SeppäläTTBöhmJPFrimanMCombination of microsatellite instability and BRAF mutation status for subtyping colorectal cancerBr J Cancer2015112121966197525973534
   PubMed Web of Science ®Google Scholar
• de CubaEMVSnaebjornssonPHeidemanDAMPrognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancersInt J Cancer201613851139114526376292
   PubMed Web of Science ®Google Scholar
• NamSKYunSKohJBRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant MetastasisPLoS One2016113e015186526991109
   PubMed Web of Science ®Google Scholar
• FujiyoshiKYamamotoGTakahashiAHigh concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastasesOncol Rep201737278579228000889
   PubMed Web of Science ®Google Scholar
• TaiebJLe MalicotKShiQPrognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon CancerJ Natl Cancer Inst20171095djw272
   PubMedGoogle Scholar
• MarisaLde ReynièsADuvalAGene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic ValuePLoS Med2013105e100145323700391
   PubMed Web of Science ®Google Scholar
• WangLCunninghamJMWintersJLBRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repairCancer Res200363175209521214500346
   PubMed Web of Science ®Google Scholar
• GkekasINovotnyJPecenLStrigardKPalmqvistRGunnarssonUMicrosatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published LiteratureAnticancer Res201737126563657429187431
   PubMed Web of Science ®Google Scholar
• Safaee ArdekaniGJafarnejadSMTanLSaeediALiGThe Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-AnalysisPLoS One2012710e4705423056577
   PubMed Web of Science ®Google Scholar
• XuQXuATZhuMMTongJLXuXTRanZHPredictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a meta-analysisJ Dig Dis201314840941623615046
   PubMed Web of Science ®Google Scholar
• YuanZ-XWangX-YQinQ-YThe Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-AnalysisPLoS One201386e6599523776587
   PubMed Web of Science ®Google Scholar
• TherkildsenCBergmannTKHenrichsen-SchnackTLadelundSNilbertMThe predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysisActa Oncol201453785286424666267
   PubMed Web of Science ®Google Scholar
• GoeyKKHEliasSGHinkeAClinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trialsBr J Cancer2017117121768177629123255
   PubMed Web of Science ®Google Scholar
• MohamedATwardyBAbdallahNClinical Impact of PI3K/BRAF Mutations in RAS Wild Metastatic Colorectal Cancer: Meta-analysis ResultsJ Gastrointest Cancer2018224
   Google Scholar
• ZhuLDongCCaoYPrognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical TrialsPLoS One2016115e015479527138801
   PubMed Web of Science ®Google Scholar